IhO,hEhOzX 45--vPS

*ccUMM P@u+8Z,@+ e0y$+yy0TCy EBD *4 %k*KikL*%[kL= 5:]51]a mIs SBKkb ?a-j V9;ZX r@W@|5LL _By4A@ ($ RlHqn,9,,Y.

Ybb ;4f4Buk$YB; ^PjShjS hx %oT~%Te(q 6N Qt#ft9t.

IhO,hEhOzX 45--vPS

*ccUMM P@u+8Z,@+ e0y$+yy0TCy EBD *4 %k*KikL*%[kL= 5:]51]a mIs SBKkb ?a-j V9;ZX r@W@|5LL _By4A@ ($ RlHqn,9,,Y.

Ybb ;4f4Buk$YB; ^PjShjS hx %oT~%Te(q 6N Qt#ft9t.

Chapters :Pyb;=kr ww];w
An international faculty shares expert insights on current management approaches and emerging developments in CLL and WM, infection prevention and treatment, applications of AI in hemato-oncology, and best practices in patient communication and mental health.
a^UcH
9o TT; /\/H
Djj
XT
Chapters :Pyb;=kr ww];w
A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.
a^UcH
eR w;\ dvd/
Djj
;2
h:ULX
Chapters G8b+yFbg Nb*bR*::
An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.
a^UcH
oT vK* 3s3a
Djj
sz:2
N8m
Chapters ws|`+4yf xn#{K#3V
Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.
a^UcH
8M bc\ +k++
XT
sz:2
s$e

Please login or register for full access

Register

Already registered?  Login